Micro-encapsulation Method for Buprenorphine Using Nested Emulsion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current micro-encapsulation methods for buprenorphine are inefficient, leading to high drug losses during encapsulation and unpredictable release rates, often resulting in initial bursts rather than steady drug delivery, which complicates treatment adherence for opioid addiction management.
Innovation Solution
A method involving the emulsification of buprenorphine in a PLGA polymer solution, followed by formation of a water-in-oil-in-water emulsion at a pH of 7.4 to 8.0, allows for efficient encapsulation with minimal losses and steady drug release over several months, using techniques like centrifugation and freeze-drying to produce micro-capsules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of substance
If conventional micro-encapsulation methods are used, then the process is simpler, but drug loss during encapsulation reaches up to ninety percent
Solution Approach 1:
The patent employs a double emulsion technique where an inner water-in-oil emulsion is further emulsified in an outer aqueous phase, creating a water-in-oil-in-water (W/O/W) structure. This nested emulsion approach allows the drug-containing inner phase to be protected within multiple polymer shells, significantly reducing drug loss during encapsulation while maintaining process feasibility through systematic phase organization.
Solution Approach 2:
The patent systematically optimizes multiple parameters including pH (maintaining aqueous phase pH between 7.4-8.0), solvent composition (using dichloromethane/acetone mixtures), polymer concentration (PLGA ratios), and emulsification conditions (sonication time, stirring speed). These parameter changes collectively improve encapsulation efficiency to over 80% while keeping the process controlled and reproducible.
2Stability of the object's composition
If conventional micro-encapsulation methods are used, then the initial process is simpler, but the drug release shows burst effects rather than steady rate
Solution Approach 1:
The nested W/O/W emulsion structure creates multiple diffusion barriers through concentric polymer shells. The drug must traverse through the inner polymer matrix and then the outer polymer layer, which eliminates burst release by controlling diffusion pathways. This nested architecture ensures steady, sustained drug release over months while the emulsion formation process remains systematically manageable.
Solution Approach 2:
The patent uses composite PLGA polymer systems with specific molecular weights and lactide-glycolide ratios (e.g., 50:50, 75:25) to create microcapsules with tuned release profiles. The composite nature of the polymer matrix, combined with the emulsion structure, provides both mechanical stability and controlled drug diffusion, achieving steady release rates without excessive process complexity.
3Quantity of substance
If higher drug loading rates are used, then the treatment efficacy is improved, but conventional methods cannot efficiently encapsulate high amounts of drug
Solution Approach 1:
The patent maintains optimal pH (7.4-8.0) throughout the emulsion process to preserve drug stability and solubility characteristics. By controlling the aqueous phase pH and using appropriate buffer systems, the method achieves high encapsulation efficiency even at 50% drug loading rates, minimizing drug loss while maximizing the quantity of active ingredient delivered in each microcapsule batch.
Solution Approach 2:
The nested emulsion structure provides enhanced protection for high concentrations of drug within the inner phase. The concentric polymer shells prevent drug leakage and degradation even when large amounts of drug are loaded, allowing the system to accommodate high drug loading rates (up to 50% and beyond) with minimal loss during the encapsulation process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves encapsulation efficiencies of over 80% with high drug loading rates and maintains a steady release rate of buprenorphine, reducing the risk of relapse in opioid addiction treatment by ensuring consistent drug levels in the patient.
Implementation Method 1
The active ingredient, preferably provided in the form of an acid salt dissolved in de-ionized water, is emulsified into a polymer solution, preferably PLGA in a relatively volatile solvent such as dichloromethane to create a water in oil emulsion.
Implementation Method 2
This emulsion is further emulsified into an aqueous solution having a pH of a between about 7.4 and 8.0 and most preferably between about 7.8 and 8.0 to create a water in oil in water emulsion.
Implementation Method 3
The polymer solvent is allowed to evaporate, causing the emulsified active ingredient and surrounding polymer matrix to precipitate, thereby forming the micro-capsules.
Implementation Method 4
The micro-capsules are separated from the suspension, washed and freeze dried
Implementation Method 5
The micro-capsules are separated from the suspension, washed and freeze dried
Data Source
AI summary
A method of preparing micro-capsules. The active ingredient, preferably provided in the form of an acid salt dissolved in a basic aqueous solution, is emulsified into a polymer solution, preferably PLGA in a relatively volatile solvent such as dichloromethane, to create a water in oil emulsion. This emulsion is further emulsified into an aqueous solution having a pH of a between about 7.4 and 8.0 and most preferably between about 7.8 and 8.0 to create a water in oil in water solution. The polymer solvent is allowed to evaporate, causing the emulsified active ingredient and surrounding polymer matrix to precipitate, thereby forming the micro-capsules. The micro-capsules are separated from the suspension, washed and freeze dried. The method has a very high encapsulation efficiency, even at high loading rates. Additionally, the dissolution rate of the micro-particles produced by the method is very steady over a long period of time.